IG Compliance Guide Will Change PBM Rebate Policies, AdvancePCS Says
Executive Summary
The HHS Inspector General's compliance guide for pharmaceutical manufacturers will "push" pharmacy benefit management companies to reform their drug rebate policies, AdvancePCS CEO David Halbert suggested at the SG Cowen health care conference in Boston March 19
You may also be interested in...
Medco Injunction Means Switches Have “Consequences,” Prosecutor Says
The Medco injunction reflects the principle that pharmacy benefit management companies should be responsible for the "consequences" of therapeutic interchange, Associate U.S. Attorney James Sheehan said during a May 11 teleconference sponsored by Pharma Audioconferences
Medco Injunction Means Switches Have “Consequences,” Prosecutor Says
The Medco injunction reflects the principle that pharmacy benefit management companies should be responsible for the "consequences" of therapeutic interchange, Associate U.S. Attorney James Sheehan said during a May 11 teleconference sponsored by Pharma Audioconferences
PBM Contracts Should Focus On Net Cost, Not Rebates, Express Scripts Says
Drug plans should focus on PBMs' abilities to lower overall net cost of prescriptions, rather than try to get a share of manufacturer rebates, Express Scripts Senior VP Thomas Boudreau told a Federal Trade Commission hearing on health care competition June 26 in Washington, D.C